Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. - Wikidata - wikimedia - TriplyDB

Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.

Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.

http://www.wikidata.org/entity/Q55039060

about

Deadly allies: the fatal interplay between platelets and metastasizing cancer cells Biomolecular characterization of CD44-fibrin(ogen) binding: distinct molecular requirements mediate binding of standard and variant isoforms of CD44 to immobilized fibrin(ogen)Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Platelets and their role in cancer evolution and immune system Metastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?Paraneoplastic thrombocytosis: the secrets of tumor self-promotion Venous thromboembolism in cancer patients: an underestimated major health problem Tumor-platelet interaction in solid tumors Immune cell promotion of metastasis Activation of blood coagulation in cancer: implications for tumour progression Bone specific immunity and its impact on metastasis Targeting tumor-stromal interactions in bone metastasis Platelet integrin α6β1 controls lung metastasis through direct binding to cancer cell-derived ADAM9.Relocation of CLIC1 promotes tumor cell invasion and colonization of fibrin.Are Platelets Cells? And if Yes, are They Immune Cells?The dual role of CD44 as a functional P-selectin ligand and fibrin receptor in colon carcinoma cell adhesion The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials Microenvironmental regulation of tumor progression and metastasis Perspective: Flicking with flow: Can microfluidics revolutionize the cancer research?Molecular mechanisms and treatment of bone metastasis.Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap.Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer.NF-E2 p45 is important for establishing normal function of platelets.Living in shear: platelets protect cancer cells from shear induced damage.Kinetics of postdiagnosis platelet count with overall survival of pancreatic cancer: a counting process approach KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.Revisiting perioperative chemotherapy: the critical importance of targeting residual cancer prior to wound healing Impact of venous thromboembolism and anticoagulation on cancer and cancer survival Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action.Inhibition of platelet function using liposomal nanoparticles blocks tumor metastasis.Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients.Tissue factor associates with survival and regulates tumour progression in osteosarcoma.A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the Fibrinogen/Albumin Ratio Role of coagulation in the recruitment of colon adenocarcinoma cells to thrombus under shear.Modelling pulmonary microthrombosis coupled to metastasis: distinct effects of thrombogenesis on tumorigenesis The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial Thrombocytosis is a significant indictor of hypercoagulability, prognosis and recurrence in gastric cancer.The role of platelets in tumour growth.Prognostic value of preoperative plasma fibrinogen level and platelet-to-lymphocyte ratio (F-PLR) in patients with localized upper tract urothelial carcinoma.D-dimer: not just an indicator of venous thrombosis but a predictor of asymptomatic hematogenous metastasis in gastric cancer patients

P2860

Q24623647-8EE6D9A0-0E85-452A-A427-0025C682A167 Q24654120-30DBCFA3-0E87-4B3A-BD2D-1E2BF07E0804 Q26748850-51AF68BB-03C9-4707-A0E5-2017B78350CE Q26769754-158C5396-6EE9-4FA6-9914-001C3F5BBE7B Q26796595-8ED35123-1AAD-4FAA-924B-15E41730E1A5 Q26825427-EE28DBBF-88AB-4529-B733-8961A607AAE1 Q26852015-7EB681BC-A518-4EE8-96AB-7115E2691BE9 Q26853099-CCDBE20B-072E-4702-89AD-A419A14A61B4 Q26991724-8A677965-4699-4893-A029-3EB699077CD6 Q26998742-406F935B-E2C9-41BA-B1AC-4290F36F8430 Q27022883-22BE6047-2475-444A-A77C-38BEA481819B Q27024561-6F4FCC66-AE6B-4EC5-AE10-C855D561691E Q27333563-B6DC567F-5C51-4B76-8E1A-DF63DCDAA3B6 Q27346341-54541DF7-4285-4BD1-946E-F72DD9CCEB67 Q28083403-4E795B78-1657-4DEF-B0BB-BD37B9348C8F Q28266614-3A797C26-B8FF-4FC5-A0E0-22B0ED0CB840 Q28296482-0308AE32-9A1A-4841-9362-C57FE13369BD Q29615504-EEAFD7C5-64C1-4CF1-94B5-5258C4FBBB73 Q30443756-8B6927CF-4DDF-4D3A-B895-6314D274382B Q30445717-2612FA43-ED69-4E12-92D6-00A33FAC6B29 Q30468939-D4A2A5A7-C0AE-4B9F-B91D-C49D436B41FF Q33245405-080657C5-21ED-44DF-9A59-A590F7392E1F Q33407515-0D92330F-C995-460D-A538-8EE6E11B770F Q33415986-6B3835E0-F775-4216-9D5F-0DB9087E0010 Q33429920-73917A6D-65E6-4E1F-A102-0C4B91B7E321 Q33430704-65FBAB60-6507-4C4C-B50A-AF19D7DF3840 Q33433283-BE78177E-FF7E-4DFE-B8AB-EB857C6AC153 Q33561203-861A27C7-5BB0-40BD-8D92-1723A8D6D963 Q33561213-9934E739-56F5-45BD-9BA0-A53C5ECB1B4D Q33588139-DEB8376A-C1C9-4886-B8A1-2B196FE51A53 Q33627109-99B03AD0-A5E2-4C5B-8343-E0E81E01F3CE Q33672303-CD1299C0-43DD-421D-85D7-202012E97DAE Q33702344-F7B3F96D-C8F1-444A-9D4F-233958191D78 Q33702668-21F52218-38AC-42E7-9DC5-62AF6E1E502E Q33743421-28737D64-D09D-4B39-AA33-52AFF392F4D0 Q33747342-20BE429B-5277-4621-89D2-18679FB2E3F2 Q33769516-7D6A727F-A720-4B7D-A7F8-9BB4455D0B6C Q33803558-CBCAB370-6339-4241-8A35-903000EB04A7 Q33829643-71278B0D-13E6-41CB-8160-21EBDF325D37 Q33830926-D5A25996-AA5F-4FE1-9F1B-271765BE4932

P2860

Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.

http://www.wikidata.org/entity/Q55039060

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Platelets and fibrin

@nl

Platelets and fibrin(ogen) inc ...... ed elimination of tumor cells.

@en

type

label

Platelets and fibrin

@nl

Platelets and fibrin(ogen) inc ...... ed elimination of tumor cells.

@en

prefLabel

Platelets and fibrin

@nl

Platelets and fibrin(ogen) inc ...... ed elimination of tumor cells.

@en

P1433

Q55039060-7C99DC2E-E13F-4615-91E2-5C3EB681D0C2

P1476

Q55039060-A0C98467-4EC1-4CB8-8580-F0EC90D88527

P2093

Q55039060-0783624D-6767-4624-9AE8-4CDDC49253D7

Q55039060-2026728A-7A21-4B3A-9933-894BE4206A4A

Q55039060-30C82238-1204-4487-806E-69E58E820ACA

Q55039060-58E92CF2-220F-43DD-8C11-EE44E492BB11

Q55039060-7771DC9C-3154-4018-BCA9-CF830CA2F3B1

Q55039060-8F1A01F1-5E24-4C37-A305-1260E60EC600

Q55039060-DD3B3759-A6AF-4C2A-87A6-A9DC5B8AB389

Q55039060-FE0F3D17-FB2B-4E6B-B6BF-A671C2125FD1

P304

Q55039060-D2388884-CF89-42CF-93CF-0BD13FEABDFE

P31

Q55039060-1C320CAB-690B-46C6-9669-780A8CDBF6BD

P356

Q55039060-BDD9F125-9E5C-4AA9-97FC-AD840CB566D7

P407

Q55039060-D8D95EB7-23C9-4C53-93C3-79A0B0D57883

P433

Q55039060-335B431C-19D4-40CE-9371-FB167EDED65A

P478

Q55039060-3FAB76E9-5F87-40E5-850C-A98907CDD9DA

P577

Q55039060-5290DF58-A8B2-4F85-A762-CD2772426813

P5875

Q55039060-1C193FE7-2B3A-45C6-A928-3DEB87AF6195

P698

Q55039060-AD56D286-2AAC-481A-8501-E0EE5ABD8E28

P356

BLOOD-2004-06-2272

P1433

P1476

Platelets and fibrin(ogen) inc ...... ed elimination of tumor cells.

@en

P2093

Christine M La Jeunesse

http://www.w3.org/2001/XMLSchema#string

Jay L Degen

http://www.w3.org/2001/XMLSchema#string

Jessica V Massari

http://www.w3.org/2001/XMLSchema#string

Joseph S Palumbo

http://www.w3.org/2001/XMLSchema#string

Kathryn E Talmage

http://www.w3.org/2001/XMLSchema#string

Keith W Kombrinck

http://www.w3.org/2001/XMLSchema#string

Markéta Jirousková

http://www.w3.org/2001/XMLSchema#string

Matthew J Flick

http://www.w3.org/2001/XMLSchema#string

P304

178-185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2004-06-2272

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8348152

http://www.w3.org/2001/XMLSchema#string

P698

15367435

http://www.w3.org/2001/XMLSchema#string